A Look Into Healthcare Sector Value Stocks
A Look Into Healthcare Sector Value Stocks
Â
Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Novartis (NYSE:NVS) - P/E: 8.4
- Talkspace (NASDAQ:TALK) - P/E: 1.43
- Organon (NYSE:OGN) - P/E: 7.14
- BioNTech (NASDAQ:BNTX) - P/E: 3.45
- Moderna (NASDAQ:MRNA) - P/E: 5.21
Most recently, Novartis reported earnings per share at $1.56, whereas in Q1 earnings per share sat at $1.46. The company's most recent dividend yield sits at 2.54%, which has increased by 0.3% from 2.24% last quarter.
Talkspace's earnings per share for Q2 sits at $-0.15, whereas in Q1, they were at -0.13. Organon's earnings per share for Q2 sits at $1.25, whereas in Q1, they were at 1.65. Most recently, the company reported a dividend yield of 3.44%, which has increased by 0.07% from last quarter's yield of 3.37%.
BioNTech saw a decrease in earnings per share from 15.97 in Q1 to $6.87 now. Moderna's earnings per share for Q2 sits at $5.24, whereas in Q1, they were at 8.58.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
Â
Â
Understanding Value Stocks
瞭解價值型股票
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
傳統上，價值型股票的定義是市場上的投資者如何評估該公司未來的增長前景。較低的市盈率是表明該公司被低估的良好基本指標，很可能被貼上價值股的標籤。
The following stocks are considered to be notable value stocks in the healthcare sector:
以下股票被認為是醫療保健板塊中值得注意的價值股：
- Novartis (NYSE:NVS) - P/E: 8.4
- Talkspace (NASDAQ:TALK) - P/E: 1.43
- Organon (NYSE:OGN) - P/E: 7.14
- BioNTech (NASDAQ:BNTX) - P/E: 3.45
- Moderna (NASDAQ:MRNA) - P/E: 5.21
- 諾華公司(紐約證券交易所股票代碼：NVS)-市盈率：8.4
- 通話空間(納斯達克：暢談)-市盈率：1.43
- 有機體(紐約證券交易所股票代碼：OGN)-市盈率：7.14
- BioNTech(納斯達克股票代碼：BNTX)-市盈率：3.45
- Moderna(納斯達克)-市盈率：5.21
Most recently, Novartis reported earnings per share at $1.56, whereas in Q1 earnings per share sat at $1.46. The company's most recent dividend yield sits at 2.54%, which has increased by 0.3% from 2.24% last quarter.
最近，諾華公佈的每股收益為1.56美元，而第一季度的每股收益為1.46美元。該公司最新的股息收益率為2.54%，較上季度的2.24%上升了0.3%。
Talkspace's earnings per share for Q2 sits at $-0.15, whereas in Q1, they were at -0.13. Organon's earnings per share for Q2 sits at $1.25, whereas in Q1, they were at 1.65. Most recently, the company reported a dividend yield of 3.44%, which has increased by 0.07% from last quarter's yield of 3.37%.
Talkspace第二季度每股收益為-0.15美元，而第一季度為-0.13美元。Organon第二季度的每股收益為1.25美元，而第一季度為1.65美元。最近，該公司公佈的股息收益率為3.44%，較上季度的3.37%增加了0.07%。
BioNTech saw a decrease in earnings per share from 15.97 in Q1 to $6.87 now. Moderna's earnings per share for Q2 sits at $5.24, whereas in Q1, they were at 8.58.
BioNTech的每股收益從第一季度的15.97美元下降到現在的6.87美元。新浪Moderna第二季度每股收益為5.24美元，而第一季度為8.58美元。
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
其重要意義在於：價值型股票可能需要一段時間才能從被低估的位置反彈。投資價值型股票的風險是，這種出現可能永遠不會成為現實。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧